Skip to content
Winnowleaf home

Condition

Sinusitis

Sinusitis is inflammation of the sinuses, the air-filled spaces behind your forehead, cheeks and nose, and it can be short-term or last more than 12 weeks. Among supplements, N-acetyl cysteine and serrapeptase are the ones people look at most, since both may thin mucus and ease swelling. Little research on any of them has been reviewed here so far, so there are no findings to report yet, and the evidence looks moderate for N-acetyl cysteine and limited for serrapeptase.

Supplements studied
2
Graded outcomes
0
Trials
2
People studied
227

Evidence by supplement

  • Strong
  • Moderate
  • Limited
  • Very limited

2 supplements

Serrapeptase: outcomes studied for Sinusitis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Mucus ProductionImproves (the measure goes up)4 studies24 people
Umckaloabo: outcomes studied for Sinusitis
GradeOutcomeEffectSizeStudiesPeopleStudies list
Nasal CongestionImproves (the measure goes up)1 study203 people

The Sinusitis Support protocol

2 primary supplements · 4 supporting supplements

See the full protocol

Shop the evidence-backed picks

Fullscript collectionImmune support: evidence-graded picksOpen on Fullscript

We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure

Studies cited

5 studies from PubMed

  1. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trialRhinology · PMID 19382496
  2. The effect of an orally administered proteolytic enzyme on the elasticity and viscosity of nasal mucusArch Otorhinolaryngol · PMID 3279939
  3. Effect of expectorants on relaxation behavior of sputum viscoelasticity in vivoBiorheology · PMID 6375756
  4. Effect of the proteolytic enzyme serrapeptase in patients with chronic airway diseaseRespirology · PMID 12911824
  5. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placeboJ Int Med Res · PMID 2257960